KRAS and cancer: Another study revealed that somatic mutations specifically in cancer-associated genes were observed in 4% of ovarian endometriosis samples, including KRAS p.G12V and PPP2R1A p.S256F along with two ARID1A nonsense mutations, p.Q403 * and p.G1926 *.